The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Editor

Share

Personal info

View

Links

Table of contents

About

Terms

 

Steven D. Gore

Sidney Kimmel Comprehensive Cancer Center

Johns Hopkins Hospital

Baltimore

MD 21231

USA

[email]@jhu.edu

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Hospital, Baltimore, MD 21231, USA. 2004 - 2006
  • The Johns Hopkins Oncology Center, Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, USA. 2002
  • The Johns Hopkins Oncology Center, Room 288, 1650 Orleans Street, Baltimore, USA. 2000 - 2001

References

  1. Six (or more) drugs in search of a mechanism: DNA methyltransferase and histone deacetylase inhibitors in the treatment of myelodysplastic syndromes. Gore, S.D. J. Natl. Compr. Canc. Netw (2006) [Pubmed]
  2. Durable molecular remissions with a single cycle of timed sequential consolidation chemotherapy in acute promyelocytic leukemia. Gore, S.D., Smith, B.D., Gojo, I., Grever, M., Kaufmann, S.H., Letendre, L., Leonard, D.G., Marcucci, G., Miller, C.B., Morris, L., Piantadosi, S., Prior, T., Stock, W., Karp, J.E. Am. J. Hematol. (2005) [Pubmed]
  3. Classification, treatment goals, and management principles for myelodysplastic syndromes. Gore, S. Cancer. Control (2004) [Pubmed]
  4. Impact of prolonged infusions of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Gore, S.D., Weng, L.J., Figg, W.D., Zhai, S., Donehower, R.C., Dover, G., Grever, M.R., Griffin, C., Grochow, L.B., Hawkins, A., Burks, K., Zabelena, Y., Miller, C.B. Clin. Cancer Res. (2002) [Pubmed]
  5. Impact of the putative differentiating agent sodium phenylbutyrate on myelodysplastic syndromes and acute myeloid leukemia. Gore, S.D., Weng, L.J., Zhai, S., Figg, W.D., Donehower, R.C., Dover, G.J., Grever, M., Griffin, C.A., Grochow, L.B., Rowinsky, E.K., Zabalena, Y., Hawkins, A.L., Burks, K., Miller, C.B. Clin. Cancer Res. (2001) [Pubmed]
  6. Modifying histones to tame cancer: clinical development of sodium phenylbutyrate and other histone deacetylase inhibitors. Gore, S.D., Carducci, M.A. Expert. Opin. Investig. Drugs (2000) [Pubmed]
 
WikiGenes - Universities